Synopsis: Foreign investors have pulled heavily from Indian equities in 2026, yet institutional demand for selected IPOs remains exceptionally strong. The gap suggests global capital is becoming more selective rather than abandoning India outright.
Foreign investors are doing something that looks contradictory at first glance: cutting exposure to Indian equities while institutional demand for some of the country’s biggest new listings remains extremely strong.
The numbers make the divergence hard to ignore. Foreign portfolio investors have net sold about ₹2.32 lakh crore from Indian equities in 2026, already exceeding the ₹1.66 lakh crore withdrawn during 2025. At the same time, major IPOs have attracted heavy institutional interest. SBI Funds Management drew nearly ₹3 lakh crore of total bids, while Manipal Health Enterprises raised ₹4,167 crore from 133 anchor investors, with both foreign and domestic institutions participating.
That does not mean FIIs are simply selling listed stocks and replacing every rupee in IPOs. The evidence points to something more nuanced: capital is becoming more selective. Foreign investors appear less willing to maintain broad exposure to India’s existing equity universe, while institutional investors, global and domestic together, continue to compete aggressively for businesses and offerings they consider attractive.
📊 FII Selectivity: The Quick Read
FPI/FII verdict: SELLING—₹2.32 lakh crore net equity outflow in 2026, already above the full-year 2025 figure.
Primary-market signal: STRONG—selected IPOs have attracted substantial institutional demand from both global and domestic investors.
FII ownership trend: 14-YEAR LOW — 14.7% as of April 2026, down from 19.9% in April 2016.
DII ownership: 18.9%—now above FII ownership.
Next major test: NSE’s IPO opens September 17, with a price band of ₹1,700–₹1,785 and a valuation of up to about ₹4.42 lakh crore.
The ₹2.32 lakh crore Outflow, Unpacked
The scale of foreign selling in 2026 has been extraordinary, but the path has not been one-way.
FPI selling accelerated sharply in March, when outflows reached roughly ₹1.17 lakh crore. Selling continued through June before the trend briefly reversed. Foreign investors turned net buyers in July and August, investing about ₹20,200 crore and ₹30,919 crore, respectively. The rebound was then interrupted in early September, when FPIs withdrew around ₹7,443 crore during September 1–4.
That reversal matters.
The tension in the market is no longer simply “FIIs are leaving India.” Instead, the flow pattern suggests foreign capital can return quickly when global conditions improve, but it can also retreat just as quickly when oil rises, US yields move higher, or the dollar strengthens.
For traders, that makes the direction of global risk appetite almost as important as the absolute size of FII selling.
Check Live: FII DII DATA | NIFTYTRADER
Why Can Investors Sell Existing Stocks but Still Back New Issues?
At first glance, exiting a listed company while subscribing to a new one looks inconsistent.
But the two decisions can serve very different purposes.
An IPO can provide access to a company or business category that has no comparable listed alternative. It also offers a structured allocation process and a defined issue price, potentially making it easier for a large institution to establish a position than buying aggressively in the secondary market and moving the price against itself.
That becomes particularly relevant when investors believe parts of the existing market are expensive but still want exposure to India’s longer-term growth story.
The important distinction is therefore not India versus no India.
It is increasingly which part of India, at what price, and through which route?
IPO Snapshot: Where Institutional Demand Is Showing Up
| Company | Issue Size | Anchor Book | Subscription |
|---|---|---|---|
| SBI Funds Management | ~₹9,795 cr | ₹2,663 cr / 129 investors | 41.66x overall; 140.11x QIB |
| Manipal Health Enterprises | ₹9,275 cr | ₹4,167 cr / 133 investors | 4.92x overall; 8.25x QIB |
| NSE | Up to ~₹22,600 cr | TBA | TBA |
SBI Funds Management and Manipal Health are particularly useful examples because both attracted substantial institutional interest, yet neither book can be treated as FII-only demand.
SBI Funds Management: A Powerful Institutional Signal
One of the clearest examples of institutional appetite came from SBI Funds Management, India’s largest asset manager.
The company raised ₹2,663 crore from 129 anchor investors ahead of its IPO. The anchor book included global institutions such as BlackRock, Goldman Sachs, Abu Dhabi Investment Authority, Morgan Stanley Asia, Fidelity, and the Government of Singapore, alongside major domestic institutions including LIC, HDFC Mutual Fund and ICICI Prudential Mutual Fund.
The wider issue generated close to ₹3 lakh crore of bids. The QIB portion excluding anchors was subscribed 140.11 times, while the overall issue was subscribed 41.66 times.
That is not evidence that FIIs alone suddenly turned bullish on India.
It is evidence that large investors, foreign and domestic, were willing to compete aggressively for a specific asset-management opportunity.
That distinction is crucial to understanding the broader market.
Manipal Health Tells the Same Story—With a Twist
Manipal Health Enterprises raised ₹4,167 crore from 133 anchor investors ahead of its ₹9,275-crore IPO. Its anchor book again combined global and domestic institutions, including Abu Dhabi Investment Authority, Morgan Stanley Asia, Allianz Global Investors, and Goldman Sachs, alongside Indian mutual funds such as ICICI Prudential Mutual Fund, Kotak Mutual Fund, Aditya Birla Sun Life Mutual Fund, UTI Mutual Fund and HSBC Mutual Fund.
The contrast with retail participation was striking.
The QIB portion excluding anchors was subscribed 8.25 times, while the retail portion was only 0.93 times. Overall subscription stood at 4.92 times.
That gap provides a useful market signal: institutional conviction can remain strong even when broader investor enthusiasm is muted.
It also shows why IPO participation should not automatically be interpreted as a broad-based bullish call on the entire Indian market.
The Longer-Term Story: Ownership Keeps Shifting
The IPO boom should not be mistaken for a full foreign-investor comeback.
FII ownership of Indian equities fell to 14.7% in April 2026, its lowest level in 14 years, compared with 19.9% in April 2016, according to JM Financial’s Fundamental Research. DII ownership stood at 18.9%, putting domestic institutions ahead of foreign investors in aggregate ownership.
JM Financial also found that DIIs increased their holdings in 39 of the 41 Nifty stocks where FIIs reduced their stakes.
That is one of the biggest structural changes in India’s equity market.
The growing domestic institutional base means the market is now less dependent on foreign flows than it was a decade ago. Mutual funds, insurers, and sustained domestic savings provide a larger counterweight when overseas investors reduce exposure.
That does not make FII flows irrelevant. It changes how much damage, or support, those flows can create on their own.
Why Selected IPOs Are Attracting Institutional Capital
New growth categories
India’s listed market is already populated by many mature businesses. IPOs create access to newer companies and sectors that may not have an established listed equivalent.
More controlled entry
A large fund trying to build a position through the secondary market can move the stock price against itself. A structured IPO allocation can reduce some of that execution friction.
Precision over breadth
Selling one listed position does not automatically mean turning bearish on India. It can represent portfolio rotation into a preferred company, sector, or growth theme.
Earlier exposure
Institutional investors may also prefer getting exposure before a company becomes broadly owned by the market or enters major indices.
The key is that these motivations can coexist with secondary-market selling. An investor can be cautious on today’s valuations while remaining constructive on selected businesses.
The Risk the IPO Boom Could Create
The strength of IPO demand does not mean every new issue is attractively priced.
Manipal Health’s institutional-versus-retail gap is a reminder that different investor groups can reach very different conclusions about valuation.
The larger concern is the sheer size of the pipeline.
Industry tracking has put the potential H2CY26 fundraising pipeline at roughly ₹4.72 lakh crore across 238 companies, including major offerings such as NSE and Reliance Jio Platforms.
That creates a potential capital-allocation squeeze.
India’s IPO, QIP and block-deal pipeline is already competing for investor capital alongside the existing listed market. Reuters previously noted that such primary-market activity could absorb a substantial share of available capital, with Abakkus estimating that around 40–50% of deployable capital could be directed toward such offerings.
If global risk appetite deteriorates at the same time that several large IPOs hit the market, investors may have to become even more selective.
That could leave some secondary-market stocks without the same liquidity support they previously received.
Track Live: IPO – Latest & Upcoming IPOs List 2026 | Check Live BSE NSE IPOs
NSE’s IPO Is the Live Stress Test
The next major test arrives on September 17, when NSE’s IPO opens.
The exchange has fixed the price band at ₹1,700–₹1,785 a share, implying a valuation of up to roughly ₹4.42 lakh crore. The offer was reduced to 126.4 million shares from 148.91 million, with the lower-than-expected price band a key reason behind the reduction.
Reuters also reported that major shareholders reduced planned sales because they expected they could potentially achieve a better valuation in the secondary market after NSE lists.
That makes NSE more than just another IPO.
It is a test of whether institutions remain willing to deploy significant capital when pricing is not as aggressive as previously expected, while derivatives activity, the exchange’s dominant revenue source, has come under pressure. Reuters reported that options account for more than 60% of NSE revenue and that August options turnover declined more than 12% year-on-year.
The key question
If NSE attracts strong institutional participation, it would reinforce the idea that capital is still available for companies viewed as strategically attractive even while broader FII exposure remains subdued.
If demand disappoints, the market may be signalling that institutional selectivity has a valuation limit.
Also Read: NSE IPO Shrinks Before Launch: ₹22,561 Crore Offer, Key Changes
What Traders Should Watch Next
Primary-market participation: Does institutional demand remain strong through NSE and the wider IPO pipeline?
Secondary-market flows: Does September’s FPI selling accelerate, or does the July-August buying trend return?
FII ownership: Does the 14.7% level stabilise, or does foreign ownership continue to decline?
Global macro signals: US Treasury yields, the dollar and crude oil remain key variables for emerging-market positioning.
Institutional rotation: Watch whether domestic investors continue absorbing foreign selling in large-cap stocks while allocating aggressively to primary issues.
The Bottom Line
India’s 2026 foreign-investor story is more complicated than a simple “FIIs out, DIIs in” narrative.
Foreign investors have reduced their overall exposure to Indian equities, with cumulative FPI outflows reaching about ₹2.32 lakh crore. Yet that does not mean institutional capital has disappeared from India. Selected IPOs have attracted enormous demand, with global and domestic institutions competing for offerings such as SBI Funds Management and Manipal Health.
The bigger shift is therefore one of selectivity.
Foreign capital can still return when conditions improve, but investors appear increasingly focused on individual businesses, valuations, and entry points rather than maintaining broad exposure to India’s listed market.
The next phase could become even more important. With a large IPO pipeline competing for capital, NSE’s September offering will help show whether institutional demand is genuinely resilient or whether it remains highly sensitive to valuation and global risk conditions.
Read Next: BRICS Summit 2026: India’s $226 Billion Trade Gap as Xi Visits Delhi
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct independent research and consult a qualified financial adviser before making investment decisions.
